Baker Brothers Life Sciences, L.P.

Track

Insider profile

Baker Brothers Life Sciences, L.P.'s trades of Celcuity Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Celcuity Inc (CELC)
Transaction date
Proposed sale
Price
490.22
Quantity 22,084
Value US$4,569,900
Transaction date
Proposed sale
Price
260.00
Quantity 671,976
Value US$174,713,760
Transaction date
Proposed sale
Price
187.27
Quantity 950,907
Value US$178,074,395
Transaction date
Proposed sale
Price
198.85
Quantity 1,008,660
Value US$200,572,041
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-14 2026-07-14
US Celcuity Inc (CELC)
PrS Proposed sale
22,084
490.22
US$4,569,900 		22,084 490.22 US$4,569,900
2026-04-23 2026-04-23
PrS Proposed sale
77,487
45.71
US$810,660 		77,487 45.71 US$810,660
2026-03-06 2026-03-06
PrS Proposed sale
60,027
457.26
US$1,993,140 		60,027 457.26 US$1,993,140
2026-03-04 2026-03-04
PrS Proposed sale
424,125
6.26
US$2,654,641 		424,125 6.26 US$2,654,641
2026-02-25 2026-02-25
PrS Proposed sale
947,479
5.81
US$5,501,316 		947,479 5.81 US$5,501,316
2026-02-24 2026-02-24
PrS Proposed sale
322,039
6.04
US$1,944,922 		322,039 6.04 US$1,944,922
2025-02-28 2025-02-28
PrS Proposed sale
671,976
260.00
US$174,713,760 		671,976 260.00 US$174,713,760
2024-12-09 2024-12-09
PrS Proposed sale
950,907
187.27
US$178,074,395 		950,907 187.27 US$178,074,395
2023-11-14 2023-11-14
PrS Proposed sale
1,008,660
198.85
US$200,572,041 		1,008,660 198.85 US$200,572,041